COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 781: Articles 7801-7810  | Next

COVID-19 and Curcumin: Using VOSviewer software to explore scientific landscape, A bibliometric analysis
Abd El Wahab, M. H.
10.1101/2022.04.10.22273674 — Posted: 2022-04-16
The effect of antidepressants on severity of COVID-19 in hospitalized patients: A systematic review and meta-analysis
Nakhaee, H., Bayati, R., Rahmanian, M., Ghaffari Jolfayi, A., ZANGIABADIAN, M., Rakhshanderou, S.
10.1101/2022.04.11.22273709 — Posted: 2022-04-16
High prevalence of burnout syndrome among medical and nonmedical residents during the COVID-19 pandemic
Pinho, R. d. N. L., Costa, T. F., Silva, N. M., Barros-Areal, A. F., Salles, A. d. M., Oliveira, A. P. R. A., Rassi, C. H. R. E., Gomes, C. M., Silva, D. L. M. d., Oliveira, F. A. R. d., Jochims, I., Vaz Filho, I. H. R., Oliveira, L. A. d. B., Rosal, M. A., Lima, M. P., Soares, M. V. A., Kurizky, P. S., Peterle, V. C. U., Gomides, A. P. M., Mota, L. M. H. d., Albuquerque, C. P. d., Simaan, C. K., Amado, V. M.
10.1101/2022.04.12.22273783 — Posted: 2022-04-16
Disentangling the rhythms of human activity in the built environment for airborne transmission risk
Susswein, Z., Rest, E. C., Bansal, S.
10.1101/2022.04.07.22273578 — Posted: 2022-04-16
COVID-19 vaccine coverage among immigrants and refugees in Alberta: a population-based cross-sectional study
MacDonald, S. E., Paudel, Y. R., Du, C.
10.1101/2022.04.11.22273644 — Posted: 2022-04-16
Rapid displacement of SARS-CoV-2 variants within Japan correlates with cycle threshold values on routine RT-PCR testing
Wright, D., Chan, C., Chaochaisit, W., Ogawa, M., Tanaka, J., Nozaki, S., Narita, S., Shimizu, E., Aoshima, H., Sato Baran, I.
10.1101/2022.04.13.22273855 — Posted: 2022-04-16
Dynamics of anti-Spike IgG antibody titer after the third BNT162b2 COVID-19 vaccination in the Japanese health care workers
Ikezaki, H., Nomura, H., Shimono, N.
10.1101/2022.04.10.22273678 — Posted: 2022-04-16
Seroprevalence, correlates and kinetics of SARS-CoV-2 Nucleocapsid IgG antibody in healthcare workers at a tertiary hospital: a prevaccine census study
Maina, D., Omuse, G., Ong'ete, G., Mugaine, P., Sayed, S., Moloo, Z., Shah, R., Etyang, A., Adam, R.
10.1101/2022.04.13.22273817 — Posted: 2022-04-16
Efficacy and Safety of Fixed Combination of Hydroxychloroquine with Azithromycin Versus Hydroxychloroquine and Placebo in Patients with Mild COVID-19: Randomized, double blind, Placebo controlled trial
Roy-Garcia, I. A., Moreno-Noguez, M., Rivas-Ruiz, R., Zapata-Tarres, M., Perez-Rodriguez, M., Ortiz-Zamora, M. A., Navarro-Susano, G., Guzman-Rivas, L., Garcia-Cortes, L. R., Palma-Lara, I., Gutierrez-Catrellon, P.
10.1101/2022.04.06.22273531 — Posted: 2022-04-16
Linking Genotype to Phenotype: Further Exploration of Mutations in SARS-CoV-2 Associated with Mild or Severe Outcomes
Agarwal, R., LeBlond, T., McAuley, E., Maier, E. J., Skarzynski, M., Voss, J., Sozhamannan, S.
10.1101/2022.04.15.22273922 — Posted: 2022-04-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).